Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06601036
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-14
Brief Title:
Sevoflurane Sedation as an Alternative for Awake Fiberoptic Intubation in Difficult Airway Patients
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Sevoflurane Sedation as an Alternative for Awake Fiberoptic Intubation in Difficult Airway Patients
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to compare patient satisfaction and intubating conditions with fiber optic intubation under sevoflurane sedation versus airway blocks in difficult airway patients
Detailed Description:
Awake fiberoptic intubation AFOI is a suitable option for anticipated difficult intubation The ideal condition for AFOI requires a calm cooperative patient with blunted airway reflexes to facilitate easy intubation especially if there is difficulty with laryngeal anatomy andor pathology
For this purpose sedative and anxiolytic agents such as benzodiazepines sevoflurane remifentanil ketamine propofol and dexmedetomidine are almost always required to relieve the patients from comfort without impairing ventilation Patient responsiveness and cooperation are almost always required
For this purpose sedative and anxiolytic agents such as benzodiazepines sevoflurane remifentanil ketamine propofol and dexmedetomidine are almost always required to relieve the patients from comfort without impairing ventilation Patient responsiveness and cooperation are almost always required
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None